Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$603K Sell
10,934
-4,244
-28% -$230K 0.23% 104
2025
Q4
$744K Buy
15,178
+4,299
+40% +$201K 0.27% 93
2025
Q3
$470K Buy
10,879
+4,180
+62% +$163K 0.18% 115
2025
Q2
$257K Buy
+6,699
New +$256K 0.1% 160

Other funds holding GSK

Texas Bank & Trust's GSK Position: Q1 2026 in Review

Texas Bank & Trust reduced its GSK (GSK) stake by 28% in Q1 2026, selling an estimated $230K and leaving 10,934 shares worth $603K. The position accounts for 0.23% of the portfolio, ranked #104.

Texas Bank & Trust first reported a position in GSK in Q2 2025 and has held it in 4 quarters since. The position peaked at $744K in Q4 2025. 1,033 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Texas Bank & Trust held 10,934 shares of GSK worth $603K as of Q1 2026.
  • Texas Bank & Trust sold 4,244 GSK shares in Q1 2026, an estimated $230K.
  • GSK made up 0.23% of Texas Bank & Trust's portfolio in Q1 2026, its #104 holding.
  • Texas Bank & Trust first reported a position in GSK in Q2 2025 and has held it in 4 quarters since.
  • Texas Bank & Trust's GSK position peaked at $744K in Q4 2025.
  • 1,033 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Texas Bank & Trust's 13F filing for Q1 2026, filed 30 Apr 2026.